May. 1 at 5:34 PM
$PFE
How many approvals, how many pipelines, how many years same price.
Is this a stock or secured bond
Pfizer, Arvinas breast cancer therapy approved by the FDA
May 01, 2026, 1:21 PM ETPfizer Inc. (PFE) Stock, ARVN StockGHBy: Dulan Lokuwithana, SA News Editor
The U.S. Food and Drug Administration on Friday approved vepdegestrant, a breast cancer therapy developed by Pfizer (PFE) and Arvinas (ARVN) under the brand name Veppanu.